drugset / Trial / NCT03113968

ELEKT-D: Electroconvulsive Therapy (ECT) vs. Ketamine in Patients With Treatment Resistant Depression (TRD)

NCT03113968

RandomizedParallel-groupOpen-labelTreatment

Summary

The goal of the study is to conduct a comparative randomized trial of electroconvulsive therapy (ECT) vs. ketamine for patients with treatment resistant depression (TRD) in a real world setting with patient reported outcomes as primary and secondary outcome measures.

Timeline

Start
2017-04-07
Primary completion
2022-10-28
Completion
2022-11-17

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ketamine Small molecule 0.5 mg/kg Intravenous